BiotechTube
Home/Edesa Biotech/Par Nijhawan
PN

Par Nijhawan

Chief Executive Officer and Director

Edesa Biotech

Therapeutic Areas

ImmunologyDermatologyAcute Care

Edesa Biotech Pipeline

DrugIndicationPhase
EB05 (paridiprubart)Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)Phase 3
EB01 (daniluromer)Chronic Allergic Contact DermatitisPhase 2b
EB06VitiligoPhase 1

Leadership Team at Edesa Biotech

MB
Michael Brooks
President and Chief Operating Officer
SL
Stephen Lemieux
Chief Financial Officer
View full Edesa Biotech profile